The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptides: Legal and Regulatory Risks 503A Compounding Pharmacies Must Understand What is BPC 157 and How Can It Benefit You? Le Jolie Med Spa The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step Industry Update: Interim 503A and 503B Bulks Lists New Revisions BPC 157 And TB 500: Background, Indications, Efficacy, And Safety GlobalRPH